Skip to main content

Prescription Drugs: Companies Typically Charge More in the United States Than in Canada

HRD-92-110 Published: Sep 30, 1992. Publicly Released: Oct 23, 1992.
Jump To:

Highlights

Pursuant to a congressional request, GAO provided information on the cost of prescription drug products, focusing on: (1) domestic and foreign price comparisons of identical prescription drugs; and (2) causes for documented price differentials.

Full Report

Full Report (42 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Health Care
Comparative analysisCost analysisDrugsFederal regulationsForeign governmentsHealth care cost controlPharmaceutical industryPharmacological researchPrice fixingPrice regulationPrescription drugs